OBJECTIVE: In 2011, the World Health Organization reported 8.7 million new cases of tuberculosis and 1.4 million tuberculosis-related deaths worldwide. The causative agent of this disease Mycobacterium tuberculosis is a notoriously persistent pathogen whose treatment requires a 6-9 month course of multiple antibiotics to clear the infection. Here, we used next generation DNA sequencing to identify several genetic factors involved in the tolerance of M. tuberculosis to the antibiotic rifampicin in the context of the biofilm, a common bacterial stress survival strategy.\ud \ud METHODS: A transposon insertion mutant library was constructed in the Erdman strain of M. tuberculosis. The library was then grown planktonically or in a biofilm and ex...
Abstract: Background Experimental data show that drug-resistance-conferring mutations are often asso...
The emergence and transmission of drug resistant strains of Mycobacterium tuberculosis (Mtb) calls f...
Tuberculosis (TB) is a global health problem estimated to kill 1.4 million people per year. Recent a...
Introduction: Drug resistant tuberculosis (TB) among the new and retreatment cases was seen to be 5%...
Tuberculosis or TB is an airborne disease caused by the non-motile bacilli, Mycobacterium tuberculos...
For model bacteria, genetic drug resistance usually arises from antibiotic-tolerant subpopulations, ...
none30siM. tuberculosis is evolving antibiotic resistance, threatening attempts at tuberculosis epid...
The World Health Organization has a goal of universal drug susceptibility testing for patients with ...
Objectives: Ninety-six percent of rifampicin resistance in Mycobacterium tuberculosis was shown to b...
M. tuberculosis is evolving antibiotic resistance, threatening attempts at tuberculosis epidemic con...
International audienceMycobacterium tuberculosis (Mtb) genetic micro-diversity in clinical isolates ...
The emergence of drug-resistant tuberculosis is a major global public health concern that threatens ...
The emergence of drug-resistant tuberculosis is a major global public health concern that threatens ...
Abstract: Background Experimental data show that drug-resistance-conferring mutations are often asso...
The emergence and transmission of drug resistant strains of Mycobacterium tuberculosis (Mtb) calls f...
Tuberculosis (TB) is a global health problem estimated to kill 1.4 million people per year. Recent a...
Introduction: Drug resistant tuberculosis (TB) among the new and retreatment cases was seen to be 5%...
Tuberculosis or TB is an airborne disease caused by the non-motile bacilli, Mycobacterium tuberculos...
For model bacteria, genetic drug resistance usually arises from antibiotic-tolerant subpopulations, ...
none30siM. tuberculosis is evolving antibiotic resistance, threatening attempts at tuberculosis epid...
The World Health Organization has a goal of universal drug susceptibility testing for patients with ...
Objectives: Ninety-six percent of rifampicin resistance in Mycobacterium tuberculosis was shown to b...
M. tuberculosis is evolving antibiotic resistance, threatening attempts at tuberculosis epidemic con...
International audienceMycobacterium tuberculosis (Mtb) genetic micro-diversity in clinical isolates ...
The emergence of drug-resistant tuberculosis is a major global public health concern that threatens ...
The emergence of drug-resistant tuberculosis is a major global public health concern that threatens ...
Abstract: Background Experimental data show that drug-resistance-conferring mutations are often asso...
The emergence and transmission of drug resistant strains of Mycobacterium tuberculosis (Mtb) calls f...
Tuberculosis (TB) is a global health problem estimated to kill 1.4 million people per year. Recent a...